Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value ($000): $5,790,264 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HORIZON THERAPEUTICS PLC | 9,000,000 | $828,360 | 14.3% | $46.60 | — | Common | G46188101 |
| — | MIRATI THERAPEUTICS INC | 4,675,000 | $800,828 | 13.8% | $42.68 | — | Common | 60468T105 |
| UTHR | UNITED THERAPEUTICS CORP | 3,000,000 | $501,810 | 8.7% | $133.00 | +25.4% | Common | 91307C102 |
| — | ACCELERON PHARMA INC | 3,000,000 | $406,830 | 7.0% | $117.18 | — | Common | 00434H108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,400,000 | $300,846 | 5.2% | $219.65 | 0.0% | Common | 92532F100 |
| — | ARENA PHARMACEUTICALS INC | 4,050,000 | $281,030 | 4.9% | $72.64 | — | Common | 040047607 |
| ARGX | ARGENX SE | 925,500 | $254,873 | 4.4% | $72.91 | — | Sponsored ADR | 04016X101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 8,000,000 | $253,280 | 4.4% | $15.05 | +175.5% | Common | 462260100 |
| — | ASCENDIS PHARMA | 1,900,000 | $244,872 | 4.2% | $128.88 | — | Sponsored ADR | 043351P10 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,425,000 | $166,682 | 2.9% | $124.06 | -6.0% | Common | 558868105 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,150,000 | $160,240 | 2.8% | $106.90 | -13.7% | Common | 803607100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,650,000 | $124,592 | 2.2% | $84.64 | -3.5% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 12,250,000 | $121,030 | 2.1% | $11.79 | +31.3% | Common | 03152W109 |
| KURA | KURA ONCOLOGY INC | 4,000,000 | $113,080 | 2.0% | $25.18 | +25.7% | Common | 50127T109 |
| — | MERSANA THERAPEUTICS INC | 6,800,000 | $110,024 | 1.9% | $23.19 | — | Common | 59045L106 |
| — | ADVERUM BIOTECHNOLOGIES INC | 8,000,000 | $78,880 | 1.4% | $11.14 | — | Common | 00773U108 |
| PMVP | PMV PHARMACEUTICALS INC | 2,360,267 | $77,629 | 1.3% | $37.32 | +5.6% | Common | 69353Y103 |
| — | CONSTELLATION PHARMACEUTICALS INC | 2,950,000 | $69,001 | 1.2% | $43.99 | — | Common | 210373106 |
| XENE | XENON PHARMACEUTICALS INC | 3,650,000 | $65,335 | 1.1% | $11.32 | +49.7% | Common | 98420N105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,500,000 | $64,500 | 1.1% | $48.41 | -9.1% | Common | 004225108 |
| — | TRILLIUM THERAPEUTICS INC | 5,700,000 | $61,218 | 1.1% | $5.91 | — | Common | 89620X506 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,500,000 | $55,900 | 1.0% | $22.26 | +1.5% | Common | 87164F105 |
| RLMD | RELMADA THERAPEUTICS INC | 1,525,000 | $53,695 | 0.9% | $40.49 | -13.6% | Common | 75955J402 |
| — | MARINUS PHARMACEUTICALS INC | 3,235,000 | $50,078 | 0.9% | $12.20 | — | Common | 56854Q200 |
| — | PRAXIS PRECISION MEDICINES INC | 1,596,495 | $47,441 | 0.8% | $43.99 | — | Common | 74006W108 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $46,762 | 0.8% | $6.26 | — | Common | 23257D103 |
| — | IVERIC BIO INC | 7,250,000 | $44,805 | 0.8% | $5.11 | — | Common | 46583P102 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,000,000 | $42,910 | 0.7% | $47.32 | 0.0% | Common | 03753U106 |
| — | DECIPHERA PHARMACEUTICALS INC | 893,000 | $40,042 | 0.7% | $46.44 | — | Common | 24344T101 |
| DSGN | DESIGN THERAPEUTICS INC | 1,468,318 | $39,702 | 0.7% | $31.14 | 0.0% | Common | 25056L103 |
| — | AVADEL PHARMACEUTICALS PLC | 4,365,000 | $39,460 | 0.7% | $7.90 | — | Sponsored ADR | 05337M104 |
| — | AMARIN CORP PLC | 6,000,000 | $37,260 | 0.6% | $8.22 | — | Sponsored ADR | 023111206 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,249,000 | $31,188 | 0.5% | $23.35 | +18.3% | Common | 89422G107 |
| MNKD | MANNKIND CORP | 7,500,000 | $29,400 | 0.5% | $3.41 | +20.3% | Common | 56400P706 |
| OLMA | OLEMA PHARMACEUTICALS INC | 876,986 | $24,599 | 0.4% | $46.89 | -8.6% | Common | 68062P106 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 3,550,000 | $18,851 | 0.3% | $9.83 | — | Sponsored ADR | 00653A107 |
| RLAY | RELAY THERAPEUTICS INC | 500,000 | $17,285 | 0.3% | $38.13 | +13.8% | Common | 75943R102 |
| — | MERUS N V | 665,000 | $13,892 | 0.2% | $20.89 | — | Common | N5749R100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $13,778 | 0.2% | $2.62 | +12.9% | Common | 372427401 |
| RNAM | AVIDITY BIOSCIENCES INC | 545,000 | $11,886 | 0.2% | $28.83 | -15.1% | Common | 05370A108 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 440,000 | $10,674 | 0.2% | $30.40 | -11.3% | Common | 09203E105 |
| — | THERAPEUTICS ACQUISITION CORP | 1,000,000 | $10,510 | 0.2% | $14.38 | — | Common | 88339T103 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,670,000 | $10,371 | 0.2% | $9.85 | -23.6% | Common | 31447P100 |
| — | BCTG ACQUISITION CORP | 800,000 | $8,896 | 0.2% | $10.84 | — | Common | 05492W103 |
| — | JOUNCE THERAPEUTICS INC | 555,000 | $5,700 | 0.1% | $10.27 | — | Common | 481116101 |
| GLPG | GALAPAGOS NV | 3,100 | $239 | 0.0% | $77.10 | — | Sponsored ADR | 36315X101 |